Lastacaft is an OTC antihistamine eye drop containing alcaftadine 0.25% that relieves itchy eyes caused by allergic conjunctivitis. Allergan, an AbbVie company, makes it. The FDA originally approved alcaftadine in 2010 and later authorized its over-the-counter sale for adults and children ages 2 and older.
The formula blocks histamine H1 and H2 receptors and stabilizes mast cells for dual-action relief. One drop works in as little as 3 minutes and lasts up to 24 hours per clinical study data. It treats pollen, ragweed, grass, pet dander, and animal hair allergens year-round. Contact lens wearers must remove lenses before use and wait 10 minutes before reinserting.
Patient reviews are mixed: Drugs.com shows 4.3 out of 10 with 61% negative experiences, while 96% of Sermo physicians would prescribe it. A clinical study confirms Lastacaft outperformed Pataday for grass and tree allergy symptoms. This review covers ingredients, side effects, cost, and who benefits most.
What Are Lastacaft Eye Drops?
Lastacaft is an antihistamine eye drop containing alcaftadine 0.25% that relieves itching caused by allergic conjunctivitis. One drop treats both eyes once daily. It’s prescription-strength relief and it’s approved for adults and children ages 2 and older.
Here’s the thing: Allergan, an AbbVie company, makes Lastacaft. The brand launched as a prescription product and later got FDA approval for over-the-counter sale. It’s available in a 5 mL bottle (60-day supply) and a two-pack of 5 mL bottles (120-day supply).
Lastacaft belongs to the drug class of ophthalmic antihistamines and decongestants. Its generic name is alcaftadine ophthalmic solution. The 0.25% concentration (2.5 mg/mL) is the only strength available.
Product Overview:
| Feature | Detail |
| Active Ingredient | Alcaftadine 0.25% |
| Drug Class | Ophthalmic Antihistamine |
| Manufacturer | Allergan (AbbVie) |
| Dosing | Once daily, 1 drop per eye |
| FDA Status | OTC (originally Rx, approved 2010) |
| Approved Ages | 2 years and older |
What Is Alcaftadine and How Does It Work?
Alcaftadine is a broad-spectrum antihistamine that blocks histamine H1 and H2 receptors and also exhibits mast cell stabilizing effects. This dual action sets it apart from simpler antihistamine eye drops. The compound carries the empirical formula C19H21N3O with a molecular weight of 307.39.
Here’s why this matters: when allergens contact the eyes, mast cells release histamine as part of the body’s immune response. Histamine then binds to receptors on eye tissue and triggers itching. Alcaftadine blocks those receptors directly and also prevents further histamine release from mast cells.
The result? Fast relief. Clinical data shows Lastacaft relieves eye itching in as little as 3 minutes. The effect lasts up to 24 hours based on 16-24 hour studies. A single daily drop maintains protection throughout the day.
What Are the Ingredients in Lastacaft Eye Drops?
Lastacaft contains one active ingredient: alcaftadine 0.25% (2.5 mg/mL), an ophthalmic antihistamine classified as an H1 receptor antagonist. No other active pharmaceutical ingredient is present in the formula. The concentration is consistent across all Lastacaft products regardless of bottle size.
In fact, alcaftadine has high affinity for histamine H1 and H2 receptors and lower affinity for H4 receptors. This receptor binding profile makes it effective against multiple histamine-mediated pathways. The mast cell stabilizing activity adds another layer of protection against allergic reactions.
What Inactive Ingredients Does Lastacaft Contain?
Lastacaft uses benzalkonium chloride 0.005% as a preservative alongside edetate disodium, sodium phosphate monobasic, purified water, and sodium chloride. Sodium hydroxide and hydrochloric acid are added to adjust the pH. These excipients maintain the sterility and stability of the ophthalmic solution.
Now here’s the thing: benzalkonium chloride (BAK) is a standard preservative in eye drops. The concentration (0.005%) is low but sufficient to prevent contamination. Users with soft contact lenses must be cautious. BAK can be absorbed by soft lens material and may cause irritation when the lens contacts the eye.
Anyone sensitive to benzalkonium chloride or any other listed ingredient should not use this product. The product label states clearly that it should not be used if the solution changes color or becomes cloudy. Such changes indicate degradation of the formula.
Full Ingredient List:
- Alcaftadine 0.25% (active antihistamine)
- Benzalkonium chloride 0.005% (preservative)
- Edetate disodium (stabilizer)
- Sodium phosphate, monobasic (buffer)
- Purified water (solvent)
- Sodium chloride (tonicity agent)
- Sodium hydroxide / hydrochloric acid (pH adjustment)
What Is Lastacaft Used For?
Lastacaft is indicated for the temporary relief of itchy eyes caused by allergic conjunctivitis triggered by pollen, ragweed, grass, animal hair, and pet dander. The FDA approved alcaftadine in 2010 for this indication. It’s not intended to treat eye irritation caused by contact lens wear or other non-allergic conditions.
To be clear: allergic conjunctivitis is an inflammation of the conjunctiva triggered by airborne allergens. The condition produces itching, redness, and watery eyes. Lastacaft targets the histamine-driven itch response directly at the ocular surface rather than systemically.
Unlike oral antihistamines, Lastacaft acts locally. This targeted application avoids the systemic side effects common with oral allergy medications. The once-daily dosing simplifies the regimen for patients managing year-round or seasonal allergy symptoms.
Does Lastacaft Work for Seasonal Allergies?
Yes. Lastacaft works against both seasonal and year-round allergens including pollen, ragweed, grass, animal hair, and pet dander. Clinical trials confirm efficacy across outdoor seasonal allergens and common indoor allergens. A single daily drop protects against all listed allergens simultaneously.
And here’s why: the dual mechanism of H1 receptor blockade and mast cell stabilization makes Lastacaft effective against multiple allergen classes. Seasonal allergens like tree pollen and ragweed trigger the same histamine cascade as indoor pet dander. Lastacaft interrupts this cascade at two points for more complete relief.
Bottom line: one clinical study showed Lastacaft was more effective than Pataday (olopatadine) for ocular itching in grass- and tree-allergic subjects. The study also reported better tolerability. That’s a concrete benchmark for how Lastacaft performs against a well-known competitor.
Can Lastacaft Be Used With Contact Lenses?
Yes. Contact lenses must be removed before applying Lastacaft, and users must wait at least 10 minutes after each dose before reinserting lenses. This precaution applies specifically to soft contact lenses. The preservative benzalkonium chloride can be absorbed by soft lens material and may cause irritation when the lens contacts the eye.
Pay attention to this: Lastacaft is not intended to treat contact lens-related eye irritation. Users whose eye redness or itching stems from lens wear should consult an eye care professional rather than self-treating with Lastacaft. The distinction between allergic conjunctivitis and lens-related irritation is medically important.
If other topical eye products are also in use, each product should be administered at least 5 minutes apart. This spacing prevents one drop from diluting another before adequate absorption. Users with multiple eye conditions should confirm the proper sequence with a pharmacist or doctor.
Contact Lens Instructions:
- Remove soft contact lenses before applying Lastacaft.
- Instill one drop of Lastacaft into each affected eye.
- Wait at least 10 minutes before reinserting contact lenses.
- Do not wear contact lenses if eyes are red or irritated.
What Are the Side Effects of Lastacaft Eye Drops?
Lastacaft carries a risk of eye irritation, burning, stinging, redness, and itching as the most commonly reported adverse effects. These reactions can occur at the application site and may persist after instillation. About 4% of users experience an allergic reaction to the product itself.
The side effect profile was evaluated in a randomized clinical study of 909 subjects over 6 weeks. The majority of users tolerated the product well during that study period. But real-world reports from patients and online reviews suggest a higher incidence of adverse reactions than the clinical trial data reflects.
So what does that mean? Users should stop using Lastacaft and contact a doctor if symptoms worsen instead of improving. Increased redness, swelling, or vision changes after application are warning signs. Continuing to use a product causing an allergic reaction can worsen the inflammatory response significantly.
What Are the Most Common Side Effects of Alcaftadine?
The most common side effects of alcaftadine include ocular burning or stinging upon instillation, eye redness, and transient blurred vision immediately after application. These effects typically resolve within minutes. Some users also report eye dryness or a foreign body sensation during initial use.
The good news? Burning or stinging on application is particularly common with preserved eye drops but often gets better with time. The benzalkonium chloride preservative contributes to this sensation in sensitive users. Some patients report the initial sting diminishing as the eye adjusts to the product.
Temporary blurred vision can occur immediately after the drop is instilled. This blurring clears quickly and doesn’t interfere with normal activities after a brief wait. Patients who need to drive or operate machinery should wait until vision is fully clear before proceeding.
Are There Serious Side Effects of Lastacaft?
Yes. Serious side effects of Lastacaft include severe allergic reactions characterized by extreme eye redness, swelling, sensitivity to light, and vision changes that require immediate medical attention. These reactions can occur in a small subset of users, estimated at less than 4%. The severity can be significant enough to require treatment with steroid eye drops.
Here’s what no one tells you: multiple patient reviews document dramatic reactions including eyes ‘appearing bloody red,’ lids swelling shut, and prolonged recovery periods lasting several days. One patient described an experience requiring 8 ophthalmologist visits and prescription steroid medication to resolve. These severe cases represent a minority of users but are clinically documented.
The official label directs users to ‘stop use and ask a doctor’ if symptoms persist or worsen. Users who experience extreme redness or swelling after application should discontinue use immediately. Reintroducing the product after a severe reaction can trigger a more intense response.
When to Seek Medical Attention:
- Eyes turn extremely red or ‘bloody’ looking after use
- Eyelids swell significantly after application
- Vision becomes blurry and does not clear quickly
- Eyes become sensitive to light after instillation
- Symptoms worsen rather than improve after use
Who Should Avoid Lastacaft Eye Drops?
Anyone with a known hypersensitivity or allergy to alcaftadine or any ingredient in Lastacaft should not use this product. This contraindication is absolute per the official label. Patients who experienced an adverse reaction to alcaftadine in the past should not attempt to use the product again.
Pregnant women should discuss Lastacaft use with a doctor before starting. Alcaftadine isn’t expected to harm an unborn baby, but the official guidance recommends physician consultation. The drug’s transfer into breast milk is unknown. That makes breastfeeding women another group that should consult a healthcare provider first.
Children under 2 years of age should not use Lastacaft. Safety and efficacy haven’t been established in this age group. Older adults (geriatric patients) have shown no differences in safety or effectiveness compared to younger adults based on clinical data.
Does Lastacaft Interact With Other Medications?
Yes. Alcaftadine has documented interactions with several systemic medications including fexinidazole and haloperidol, which may increase the risk of adverse effects when combined with alcaftadine. Hyoscyamine represents another interaction where alcaftadine may increase anticholinergic activity. These interactions are classified as moderate severity.
For example, when used with other eye drops, each product should be administered at least 5 minutes apart. This spacing prevents dilution and maintains the efficacy of each medication. The 5-minute rule applies to all topical ophthalmic products, not just prescription medications.
Users taking oral antihistamines alongside Lastacaft should inform their doctor. Combining topical and oral antihistamines may increase the total antihistamine load on the body. The interaction risk is generally low for topical ophthalmic use, but medical oversight is advisable for complex medication regimens.
Known Drug Interactions:
| Drug | Interaction Type | Severity |
| Fexinidazole | Increased adverse effect risk | Moderate |
| Haloperidol | Increased QTc prolongation risk | Moderate |
| Hyoscyamine | Increased anticholinergic activity | Moderate |
What Do Lastacaft Reviews Say?
Lastacaft has an average rating of 4.3 out of 10 on Drugs.com from 31 reviews, with 32% of reviewers reporting a positive experience and 61% reporting a negative experience. WebMD ratings show 2.8 out of 5 from 25 reviews with about 36% positive responses. Sermo physician ratings are significantly more favorable at approximately 3.5 out of 5, with 96% of physicians indicating they’d prescribe it.
Here’s the part most people miss: the contrast between physician ratings and patient reviews is notable. Physicians who observe the drug across many patients rate it highly. Individual patients who had negative experiences tend to report more strongly online. This selection bias affects the overall review score disproportionately toward negative outcomes.
Walmart customer reviews tell a different story. Multiple verified purchasers describe immediate relief from allergy symptoms and overall satisfaction with the product. The discrepancy between retail reviews and medical platform reviews may reflect differences in how each patient group uses and evaluates the product.
Review Ratings Summary:
| Platform | Rating | Sample Size | Positive Rate |
| Drugs.com | 4.3/10 | 31 reviews | 32% |
| WebMD | 2.8/5 | 25 reviews | 36% |
| Sermo (Physicians) | ~3.5/5 | Physician data | 96% would prescribe |
What Do Patients Like About Lastacaft?
Patients who respond well to Lastacaft consistently praise its fast action, with many reporting relief within minutes of the first dose. Users describe the once-daily convenience as a major advantage. Several reviewers specifically note they switched from Pataday or other brands and found Lastacaft more effective.
Think of it this way: one highly-voted review on WebMD described a pre-treatment itch severity of 9 out of 10. After applying Lastacaft, the user reported total relief within minutes. That type of dramatic, rapid response is echoed across multiple positive reviews from satisfied users.
On Walmart, verified purchasers describe Lastacaft as the best allergy eye drop they’ve tried after years of trying other products. Users also appreciate the prescription-strength formula available without a doctor visit. The FDA-approved, non-harmful ingredient profile is mentioned as a key trust factor among parents using it for children.
What Are Common Complaints About Lastacaft?
The most frequently reported complaint about Lastacaft is a severe allergic reaction causing extreme eye redness, swelling, and burning that multiple patients describe as the worst medication experience of their lives. These reactions typically appear after 2-4 weeks of use or upon reintroduction after a break. The reactions can be dramatic enough to resemble conjunctivitis.
In fact, several reviewers describe a pattern where the product worked initially, then triggered a severe reaction after continued use. One user reported eyes looking ‘like eyeballs were bleeding’ after reintroducing the drops. Another described needing to replace all skincare and makeup while trying to identify the cause of the reaction before realizing Lastacaft was responsible.
Price is another recurring complaint. Users pay between $18 and $70 (USD) depending on the retailer and insurance situation. Those without coverage find the cost high for a daily-use product. At least one reviewer reported being charged full price despite seeing a clearance sticker on the box.
How Much Does Lastacaft Cost?
Lastacaft typically retails between $18 and $70 (USD) per bottle, with price variation depending on the retailer, bottle size, and whether the buyer has insurance coverage. A single 5 mL bottle (60-day supply) is available at most major retailers. The two-pack (120-day supply, 2 x 5 mL bottles) provides better value per dose.
The good news? Coupons and savings programs are available directly from Allergan’s Lastacaft website. These programs can significantly reduce out-of-pocket cost for eligible patients. Pharmacy discount cards and GoodRx-style programs may also reduce the price below the retail rate at participating pharmacies.
The cost per dose is relatively low when calculated on a daily basis. A single 5 mL bottle delivers 60 doses at approximately $0.30 to $1.17 (USD) per day depending on purchase price. This per-dose economics can improve the value perception for chronic allergy sufferers.
Lastacaft Pricing by Format:
| Format | Size | Supply | Approx. Price (USD) |
| Single bottle | 5 mL | 60-day | $18-$45 |
| Two-pack | 2 x 5 mL | 120-day | $35-$70 |
Is Lastacaft Worth the Price?
Yes. Lastacaft delivers prescription-strength antihistamine action without a doctor visit, which makes the cost justified relative to prescription alternatives and co-pay expenses. Users who achieve complete daily relief from a single drop typically rate the value highly. The 24-hour protection window also eliminates the need for multiple daily doses.
But here’s what to consider: for patients who experience adverse reactions, the cost calculation changes significantly. One reviewer reported spending $200 (USD) on the product and triple that amount on medical treatment for the resulting side effects. The risk of adverse reactions adds a potential hidden cost that buyers should factor into their decision.
Compared to competitors like Pataday, Lastacaft also offers twice the volume per bottle. This size advantage means each purchase lasts longer. A clinical study supports Lastacaft’s superior efficacy for grass and tree allergies compared to Pataday. That further strengthens the value argument for appropriate candidates.
Where Can You Buy Lastacaft Eye Drops?
Lastacaft is available for purchase both in stores and online at most major retailers without a prescription since receiving FDA over-the-counter approval. Physical locations include pharmacies, supercenters, and drug stores across the United States. The product is also available through online retailers for home delivery.
Major retailers that carry Lastacaft include Walmart and other large pharmacy chains. The official Lastacaft website provides a store locator to find local availability. Buyers can also order through mail-order pharmacy services, which sometimes offer pricing advantages for recurring purchases.
Both bottle sizes (5 mL and 2 x 5 mL) are typically stocked at major retailers. Availability of the larger two-pack may vary by location. Checking the retailer’s website before visiting the store confirms current in-store stock status and online pricing.
Is Lastacaft Available Over the Counter?
Yes. Lastacaft is now available over the counter (OTC) in the United States after the FDA approved its switch from prescription-only to OTC status. No doctor visit or prescription is required to purchase it. This change expanded access for allergy patients who previously needed a physician to prescribe alcaftadine.
And here is the best part: the OTC formula is identical to the original prescription formula. The packaging has changed but the active ingredient concentration (alcaftadine 0.25%) remains the same. Patients who used prescription Lastacaft can purchase the OTC version with the same therapeutic expectations.
The drug is approved for OTC use in adults and children ages 2 and older. Parents purchasing the product for children under 2 should consult a doctor first. The OTC label specifies the standard adult and pediatric dose of one drop in each affected eye once daily.
Is Lastacaft FDA Approved and Legit?
Yes. Lastacaft received initial FDA approval in 2010 and has since accumulated 5 total FDA approvals including the more recent over-the-counter authorization. The manufacturer Allergan is an established pharmaceutical company owned by AbbVie. The product is manufactured under FDA-regulated standards for ophthalmic drug products.
This is important: clinical trials supporting FDA approval included a randomized study of 909 subjects monitored over 6 weeks. No overall differences in safety or effectiveness were observed between elderly and younger subjects during these trials. Pediatric safety has been established for ages 2 and older through appropriate study designs.
Active clinical research continues. Three studies are currently evaluating Lastacaft, including at least one phase 3 trial actively recruiting for allergic conjunctivitis treatment. Ongoing research indicates the manufacturer and scientific community continue to investigate alcaftadine’s therapeutic potential.
Is Lastacaft Better Than Pataday?
Yes. Based on clinical data, Lastacaft was more effective than Pataday for ocular itching in grass- and tree-allergic subjects and was also better tolerated in head-to-head comparison study conditions. Pataday contains olopatadine, another antihistamine eye drop used for allergic conjunctivitis. Both products are once-daily and available over the counter.
Physician ratings on Sermo compare the two favorably for Lastacaft. The 96% physician recommendation rate suggests strong professional endorsement. However, patient review scores are lower for Lastacaft than for some alternatives. That reflects the subset of patients who experience adverse reactions.
The key differentiator is Lastacaft’s dual mechanism: H1 receptor blockade plus mast cell stabilization. Pataday primarily works through olopatadine’s antihistamine and mast cell stabilizing properties. For patients who didn’t achieve adequate relief with Pataday, Lastacaft represents a clinically validated alternative worth trying.
Lastacaft vs Pataday Comparison:
| Feature | Lastacaft | Pataday |
| Active Ingredient | Alcaftadine 0.25% | Olopatadine |
| Dosing | Once daily | Once daily |
| OTC Availability | Yes | Yes |
| Clinical Efficacy (grass/tree) | Superior in study | Comparison baseline |
| Volume per Bottle | 2x more than leading brand | Standard volume |
Should You Try Lastacaft Eye Drops?
Lastacaft is a clinically validated, FDA-approved option for allergy sufferers seeking once-daily relief from itchy eyes caused by pollen, ragweed, grass, and pet dander. The prescription-strength formula is now accessible without a doctor visit. Fast onset (3 minutes) and long duration (24 hours) make it one of the more convenient antihistamine eye drops available.
That said, the risk of adverse reactions in a subset of users is a real consideration. Approximately 4% of users experience significant allergic reactions to the product. Starting with a single application and monitoring the response for 24-48 hours before committing to daily use is a prudent approach for new users.
Patients with mild to moderate seasonal eye allergies who haven’t responded to oral antihistamines represent the best candidates. Those who have previously reacted to alcaftadine or benzalkonium chloride should avoid it entirely. A pharmacist or eye care professional can help determine whether Lastacaft fits a specific allergy profile.
Who Gets the Best Results With Lastacaft?
Patients with allergic conjunctivitis triggered by outdoor seasonal allergens get the best results from Lastacaft, particularly those with grass and tree pollen sensitivities based on clinical comparison data. Users who need once-daily dosing for convenience and those who haven’t responded to simpler antihistamine drops also report strong outcomes. Children ages 2 and older with diagnosed allergic conjunctivitis are another group where the drug performs well under physician guidance.
Patients with contact lens use need to follow the 10-minute wait rule consistently. Those who can’t comply with the lens removal and reinsertion timing may find the product less practical for daily use. An eye care provider can advise on alternative formulations for contact lens wearers with complex allergy needs.
Users who tried Lastacaft previously without adverse reactions and got good results can continue with the OTC version confidently. The formula is unchanged from the prescription version. For first-time users, starting during a low-allergen period allows assessment of tolerability before peak allergy season begins.